Market News

Unveiling Trevi Therapeutics’ Triumph: A Dive into Q4 2023 Earnings Unveiling Trevi Therapeutics’ Triumph: A Dive into Q4 2023 Earnings

by Ron Finklestien

Published On: March 20, 2024 9:53 pm

TRVI stock - TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023

Source: Pavel Kapysh / Shutterstock

Trevi Therapeutics (NASDAQ:TRVI) recently unveiled Q4 2023 earnings data.

The earnings per share for Trevi Therapeutics stood at -8 cents, beating the analyst consensus of -9 cents.
Despite solid EPS performance, the company did not report any revenue for the quarter.

InvestorPlace Earnings, fueled by TradeSmith data, provides automated coverage of quarterly earnings, bringing forth crucial insights such as EPS and revenue figures, and how a company measures up against analyst predictions. These pieces are machine-curated to swiftly deliver the latest data to our audience. For any feedback or corrections, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/trvi-stock-earnings-trevi-therapeutics-for-q4-of-2023/.

Unveiling Trevi Therapeutics’ Triumph: A Dive into Q4 2023 Earnings Unveiling Trevi Therapeutics’ Triumph: A Dive into Q4 2023 Earnings

The free Daily Market Overview 250k traders and investors are reading

Latest Stories

Latest

Stocks Facing Heavy Insider Selling: Three to Watch

Latin America Dominates Mining M&A Activity, Accounting for 75% of Transactions: McKinsey

Embrace the Journey of AI Evolution

Understanding the 81% Decline of Figma Stock: Unseen IPO Factors Affecting Retail Investors

Navigating the Future of Technology Disruption

A Game-Changing Development That Went Unnoticed by Many Investors

Categories

Links

Follow Us On